Dorsey Wright & Associates Argenx Se Transaction History

Dorsey Wright & Associates

$408 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$338.91 - $506.01 $143,020 - $213,536	-422 Reduced 7.59%	5,136 $1.95 Million
Q3 2023 Nov 07, 2023	SELL	$369.35 - $548.43 $126,317 - $187,563	-342 Reduced 5.8%	5,558 $2.73 Million
Q2 2023 Jul 26, 2023	SELL	$360.14 - $422.58 $206,720 - $242,560	-574 Reduced 8.87%	5,900 $2.3 Million
Q1 2023 Apr 19, 2023	SELL	$334.23 - $403.65 $126,004 - $152,176	-377 Reduced 5.5%	6,474 $2.41 Million
Q4 2022 Feb 14, 2023	BUY	$342.17 - $402.31 $2.34 Million - $2.76 Million	6,851 New	6,851 $2.6 Million
Q2 2021 Jul 23, 2021	SELL	$257.11 - $319.92 $8.85 Million - $11 Million	-34,421 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$268.3 - $380.31 $669,676 - $949,253	2,496 Added 7.82%	34,421 $9.48 Million
Q4 2020 Jan 28, 2021	SELL	$248.13 - $308.36 $157,066 - $195,191	-633 Reduced 1.94%	31,925 $9.39 Million
Q3 2020 Oct 28, 2020	SELL	$215.51 - $272.51 $356,453 - $450,731	-1,654 Reduced 4.83%	32,558 $8.55 Million
Q2 2020 Jul 23, 2020	SELL	$127.44 - $232.72 $376,967 - $688,385	-2,958 Reduced 7.96%	34,212 $7.76 Million
Q1 2020 Apr 20, 2020	SELL	$108.83 - $165.23 $462,092 - $701,566	-4,246 Reduced 10.25%	37,170 $4.9 Million
Q4 2019 Jan 31, 2020	SELL	$106.59 - $164.21 $190,796 - $293,935	-1,790 Reduced 4.14%	41,416 $6.65 Million
Q3 2019 Oct 31, 2019	SELL	$113.31 - $150.51 $79,770 - $105,959	-704 Reduced 1.6%	43,206 $4.92 Million
Q2 2019 Jul 02, 2019	SELL	$115.0 - $141.58 $349,140 - $429,836	-3,036 Reduced 6.47%	43,910 $6.22 Million
Q1 2019 Apr 04, 2019	BUY	$98.85 - $134.59 $20,659 - $28,129	209 Added 0.45%	46,946 $5.86 Million
Q4 2018 Jan 07, 2019	SELL	$63.81 - $109.82 $1.03 Million - $1.77 Million	-16,124 Reduced 25.65%	46,737 $4.49 Million
Q3 2018 Oct 12, 2018	SELL	$75.5 - $96.63 $2.36 Million - $3.03 Million	-31,317 Reduced 33.25%	62,861 $4.77 Million
Q2 2018 Jul 06, 2018	BUY	$74.84 - $100.16 $7.05 Million - $9.43 Million	94,178 New	94,178 $7.87 Million

Others Institutions Holding ARGX

# of Institutions

403

Shares Held

30.8M

Call Options Held

376K

Put Options Held

489K

Price T Rowe Associates Inc Baltimore, MD

5.82M
Shares

$3.82 Billion
0.36% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

3.51M
Shares

$2.31 Billion
2.99% of portfolio
Janus Henderson Group PLC London, X0

2.48M
Shares

$1.63 Billion
0.72% of portfolio
Capital World Investors Los Angeles, CA

1.7M
Shares

$1.12 Billion
0.15% of portfolio
Avoro Capital Advisors LLC New York, NY

1.24M
Shares

$813 Million
10.11% of portfolio

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $36.3B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Dorsey Wright & Associates with notifications on news.

Account